Ashmun R - Search Results

1

Haploinsufficiency of the lysosomal sialidase NEU1 results in a model of pleomorphic rhabdomyosarcoma in mice.

Machado ER, van de Vlekkert D, Sheppard HS, Perry S, Downing SM, Laxton J, Ashmun R, Finkelstein DB, Neale GA, Hu H, Harwood FC, Koo SC, Grosveld GC, d'Azzo A. Machado ER, et al. Among authors: ashmun r. Commun Biol. 2022 Sep 20;5(1):992. doi: 10.1038/s42003-022-03968-8. Commun Biol. 2022. PMID: 36127469 Free PMC article.

2

Requirement for antiapoptotic MCL-1 during early erythropoiesis.

Turnis ME, Kaminska E, Smith KH, Kartchner BJ, Vogel P, Laxton JD, Ashmun RA, Ney PA, Opferman JT. Turnis ME, et al. Among authors: ashmun ra. Blood. 2021 Apr 8;137(14):1945-1958. doi: 10.1182/blood.2020006916. Blood. 2021. PMID: 33512417 Free PMC article.

3

Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF.

Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G, Sherr CJ. Kamijo T, et al. Among authors: ashmun ra. Cell. 1997 Nov 28;91(5):649-59. doi: 10.1016/s0092-8674(00)80452-3. Cell. 1997. PMID: 9393858 Free article.

4

Relationship of tumor-cell ploidy to histologic subtype and treatment outcome in children and adolescents with unresectable rhabdomyosarcoma.

Shapiro DN, Parham DM, Douglass EC, Ashmun R, Webber BL, Newton WA Jr, Hancock ML, Maurer HM, Look AT. Shapiro DN, et al. Among authors: ashmun r. J Clin Oncol. 1991 Jan;9(1):159-66. doi: 10.1200/JCO.1991.9.1.159. J Clin Oncol. 1991. PMID: 1985166

5

Tumor-cell DNA content predicts outcome in children and adolescents with clinical group III embryonal rhabdomyosarcoma. The Intergroup Rhabdomyosarcoma Study Committee of the Children's Cancer Group and the Pediatric Oncology Group.

Pappo AS, Crist WM, Kuttesch J, Rowe S, Ashmun RA, Maurer HM, Newton WA, Asmar L, Luo X, Shapiro DN. Pappo AS, et al. Among authors: ashmun ra. J Clin Oncol. 1993 Oct;11(10):1901-5. doi: 10.1200/JCO.1993.11.10.1901. J Clin Oncol. 1993. PMID: 8410116

6

Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6.

Hirai H, Roussel MF, Kato JY, Ashmun RA, Sherr CJ. Hirai H, et al. Among authors: ashmun ra. Mol Cell Biol. 1995 May;15(5):2672-81. doi: 10.1128/MCB.15.5.2672. Mol Cell Biol. 1995. PMID: 7739547 Free PMC article.

7

Rapamycin causes poorly reversible inhibition of mTOR and induces p53-independent apoptosis in human rhabdomyosarcoma cells.

Hosoi H, Dilling MB, Shikata T, Liu LN, Shu L, Ashmun RA, Germain GS, Abraham RT, Houghton PJ. Hosoi H, et al. Among authors: ashmun ra. Cancer Res. 1999 Feb 15;59(4):886-94. Cancer Res. 1999. PMID: 10029080

8

Complementation of growth factor receptor-dependent mitogenic signaling by a truncated type I phosphatidylinositol 4-phosphate 5-kinase.

Davis JN, Rock CO, Cheng M, Watson JB, Ashmun RA, Kirk H, Kay RJ, Roussel MF. Davis JN, et al. Among authors: ashmun ra. Mol Cell Biol. 1997 Dec;17(12):7398-406. doi: 10.1128/MCB.17.12.7398. Mol Cell Biol. 1997. PMID: 9372970 Free PMC article.

9

Macrophage lineage switching of murine early pre-B lymphoid cells expressing transduced fms genes.

Borzillo GV, Ashmun RA, Sherr CJ. Borzillo GV, et al. Among authors: ashmun ra. Mol Cell Biol. 1990 Jun;10(6):2703-14. doi: 10.1128/mcb.10.6.2703-2714.1990. Mol Cell Biol. 1990. PMID: 2160584 Free PMC article.

10

Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle.

Matsushime H, Roussel MF, Ashmun RA, Sherr CJ. Matsushime H, et al. Among authors: ashmun ra. Cell. 1991 May 17;65(4):701-13. doi: 10.1016/0092-8674(91)90101-4. Cell. 1991. PMID: 1827757

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

70 results

Search Page